Novo Nordisk Commits €432m to expand Irish GLP-1 production
Danish multinational pharmaceutical company Novo Nordisk has announced a significant capital investment of €432 million to expand its manufacturing facility in Athlone, Ireland, specifically to ramp up production of oral GLP-1 treatments. The initiative, announced March 2, focuses on increasing capacity for the tablet version of its weight-loss drug, Wegovy, and is intended to serve markets outside the United States.…
Uniphar bolsters tech with TouchStore acquisition
Dublin-based healthcare services group Uniphar has acquired TouchStore, a provider of dispensing and retail management software. This transaction represents a transformational step for Uniphar’s supply chain and retail division as it seeks to bolster its technological capabilities. TouchStore is widely recognised in Ireland for providing essential software to pharmacy teams, and its integration is expected to significantly enhance Uniphar’s service…